# Evolutionary Integration and Glucocorticoid Regulation of the Respiratory System: Structure, Function, and Homeostatic Adaptation

**Authors:** Gianfranco Umberto Meduri, Antoni Torres

PMC · DOI: 10.3390/medsci14010090 · Medical Sciences · 2026-02-14

## TL;DR

This paper explores how the glucocorticoid receptor alpha (GRα) evolved to regulate the respiratory system's structure and function across development and disease.

## Contribution

The paper introduces GRα as a system-level integrator of respiratory homeostasis, linking evolutionary, developmental, and physiological regulation.

## Key findings

- GRα is essential for lung development and postnatal adaptation through mesenchyme-epithelium signaling.
- GRα maintains alveolar stability and coordinates immune, vascular, and metabolic functions in the mature lung.
- GRα interacts with circadian and hypoxia pathways to enhance energy production and redox homeostasis during stress.

## Abstract

The vertebrate respiratory system arose under evolutionary pressures that linked increasing atmospheric oxygen levels to the metabolic demands of mitochondria. This transition—from ancestral gill-based exchange to the highly alveolated mammalian lung—was accompanied by the emergence of a hormonal regulatory axis centered on the glucocorticoid receptor alpha (GRα). Over time, GRα became deeply integrated into the architecture and function of the respiratory system, aligning pulmonary performance with organismal homeostasis across different developmental stages, environmental challenges, and disease states. This review combines evolutionary, embryological, and molecular evidence to explain how GRα shapes respiratory structure and function. We trace the evolution from ancient oxygen-sensing systems to mammalian alveoli and endothelial adaptations, demonstrating how conserved developmental pathways (including WNT, FGF, BMP, and SHH) are repurposed during both organogenesis and repair. Genetic models show that GRα is essential for preparing the lung for postnatal life, coordinating the reciprocal signaling between mesenchyme and epithelium that drives branching, septation, extracellular matrix organization, and the development of functional alveolar units. In the mature lung, GRα maintains the stability of the alveolar–capillary interface and coordinates immune, vascular, and metabolic functions to support efficient gas exchange. Its actions also extend to red blood cell biology and the regulation of stress erythropoiesis, linking pulmonary oxygen management with systemic oxygen delivery. Mechanistically, GRα interacts with circadian and hypoxia pathways and activates mitochondrial programs that enhance energy production and redox homeostasis during stress. By integrating these regulatory layers across developmental and physiological contexts, this review reframes GRα not simply as a stress-response receptor but as a non-redundant system-level integrator of respiratory homeostasis. Understanding this layered control not only explains the benefits of antenatal corticosteroids but also highlights the therapeutic value of phase-specific, precision modulation of the GC–GRα axis—along with strategies that support GC–GR signaling—to reestablishing and maintaining homeostasis in acute and chronic pulmonary disorders.

## Linked entities

- **Genes:** gra (gravel) [NCBI Gene 251211], Wnt (protein Wnt-2) [NCBI Gene 100641115], FGF (fibroblast growth factor) [NCBI Gene 582058], dpp (decapentaplegic) [NCBI Gene 33432], SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469]
- **Proteins:** gra (gravel)

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, NCOA1 (nuclear receptor coactivator 1) [NCBI Gene 8648] {aka F-SRC-1, KAT13A, RIP160, SRC1, bHLHe42, bHLHe74}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, SFTPC (surfactant protein C) [NCBI Gene 6440] {aka BRICD6, PSP-C, SFTP2, SMDP2, SP-C}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, DUSP1 (dual specificity phosphatase 1) [NCBI Gene 1843] {aka CL100, HVH1, MKP-1, MKP1, PTPN10}, CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, GPX3 (glutathione peroxidase 3) [NCBI Gene 2878] {aka GPx-P, GSHPx-3, GSHPx-P}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, IPO13 (importin 13) [NCBI Gene 9670] {aka IMP13, KAP13, LGL2, RANBP13}, CXCL5 (C-X-C motif chemokine ligand 5) [NCBI Gene 6374] {aka ENA-78, SCYB5}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, ATG7 (autophagy related 7) [NCBI Gene 10533] {aka APG7-LIKE, APG7L, GSA7, SCAR31}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}, EPOR (erythropoietin receptor) [NCBI Gene 2057] {aka EPO-R}, FOXC2 (forkhead box C2) [NCBI Gene 2303] {aka FKHL14, LD, MFH-1, MFH1}, NR3C2 (nuclear receptor subfamily 3 group C member 2) [NCBI Gene 4306] {aka MCR, MLR, MR, NR3C2VIT}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, VCAN (versican) [NCBI Gene 1462] {aka CSPG2, ERVR, GHAP, PG-M, WGN, WGN1}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, HDAC2 (histone deacetylase 2) [NCBI Gene 3066] {aka HD2, KDAC2, RPD3, YAF1}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662] {aka CMD1, CMPD1, ENH13, SRA1, SRXX2, SRXY10}, BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406] {aka ARNTL, ARNTL1, BMAL1c, JAP3, MOP3, PASD3}, FGF10 (fibroblast growth factor 10) [NCBI Gene 2255] {aka LADD3}, CLDN8 (claudin 8) [NCBI Gene 9073] {aka HEL-S-79}, TSC22D3 (TSC22 domain family member 3) [NCBI Gene 1831] {aka DIP, DSIPI, GILZ, TSC-22R}, MDK (midkine) [NCBI Gene 4192] {aka ARAP, MK, NEGF2}, NCOA2 (nuclear receptor coactivator 2) [NCBI Gene 10499] {aka GRIP1, KAT13C, NCoA-2, SRC-2, SRC2, TIF2}, HSPA4 (heat shock protein family A (Hsp70) member 4) [NCBI Gene 3308] {aka APG-2, HEL-S-5a, HS24/P52, HSPH2, RY, hsp70}, Hsd11b1 (hydroxysteroid 11-beta dehydrogenase 1) [NCBI Gene 15483], VHL (von Hippel-Lindau tumor suppressor) [NCBI Gene 7428] {aka HRCA1, RCA1, VHL1, pVHL}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631] {aka ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, MUC5B (mucin 5B, oligomeric mucus/gel-forming) [NCBI Gene 727897] {aka MG1, MUC-5B, MUC5, MUC9}, HSP90AA1 (heat shock protein 90 alpha family class A member 1) [NCBI Gene 3320] {aka EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, MYL2 (myosin light chain 2) [NCBI Gene 4633] {aka CMH10, MFM12, MLC-2, MLC-2s/v, MLC-2v, MLC2}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469] {aka HHG1, HLP3, HPE3, MCOPCB5, SMMCI, ShhNC}, ADAMTS12 (ADAM metallopeptidase with thrombospondin type 1 motif 12) [NCBI Gene 81792] {aka PRO4389}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, CCL16 (C-C motif chemokine ligand 16) [NCBI Gene 6360] {aka CKb12, HCC-4, ILINCK, LCC-1, LEC, LMC}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}
- **Diseases:** airway dilation (MESH:D002311), infection (MESH:D007239), dyspnea (MESH:D004417), Diamond-Blackfan anemia (MESH:D029503), preterm delivery (MESH:D047928), acute and chronic pulmonary disorders (MESH:D012120), cancer (MESH:D009369), hypertrophy (MESH:D006984), vascular and inflammatory disease (MESH:D014652), ischemic (MESH:D002545), inflammatory lung disease (MESH:D008171), weakness (MESH:D018908), acute mountain sickness (MESH:D000532), immune dysfunction (MESH:D007154), toxicity (MESH:D064420), vascular leak (MESH:D019559), vascular dysfunction (MESH:D002561), pulmonary edema (MESH:D011654), ALI (MESH:D055371), lung immaturity (MESH:D013724), acute and chronic lung disease (MESH:D055370), asthma (MESH:D001249), edema (MESH:D004487), arthritis (MESH:D001168), chronic inflammation (MESH:D007249), injury to (MESH:D014947), neurodegeneration (MESH:D019636), shock (MESH:D012769), anemia (MESH:D000740), glucocorticoid resistance (MESH:C564221), endotoxemia (MESH:D019446), critical (MESH:D016638), fibrosis (MESH:D005355), respiratory disease (MESH:D012140), hypertension (MESH:D006973), mitochondrial dysfunction (MESH:D028361), developmental abnormalities (MESH:D006130), neonatal hypoventilation (MESH:D007040), steroid resistance (MESH:D009404), metabolic disorders (MESH:D008659), impaired ventilation (MESH:D053717), neuromuscular disorders (MESH:D009468), acute and (MESH:D000208), ARDS (MESH:D012128), tissue injury (MESH:D017695), congenital lung disorders (MESH:C562992), respiratory-muscle fatigue (MESH:D012133), Hypoxia (MESH:D000860), pulmonary hypertension (MESH:D006976), sepsis (MESH:D018805), chronic (MESH:D002908), tracheoesophageal fistulas (MESH:D014138), neonatal respiratory distress syndrome (MESH:D012127), respiratory failure (MESH:D012131), hemorrhage (MESH:D006470), Hypoxic (MESH:D002534), fatigue (MESH:D005221), COPD (MESH:D029424), pneumonia (MESH:D011014), hypercapnia (MESH:D006935)
- **Chemicals:** catecholamine (MESH:D002395), dexamethasone (MESH:D003907), cortisol (MESH:D006854), TCA (MESH:D014238), CORT113176 (MESH:C000623379), itaconate (MESH:C005229), K (MESH:D011188), sodium (MESH:D012964), O2 (MESH:D010100), NO (MESH:D009569), calcium (MESH:D002118), chloride (MESH:D002712), ROS (MESH:D017382), ATP (MESH:D000255), steroid (MESH:D013256), ion (MESH:D007477), CO2 (MESH:D002245), lipid (MESH:D008055), RU-486 (MESH:D015735)
- **Species:** Crocodylidae (crocodiles, family) [taxon 8493], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Actinopterygii (fishes, superclass) [taxon 7898], Polypterus (genus) [taxon 8290]
- **Cell lines:** AT1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), alveolar type I/type II epithelial cells — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_VR37), ASM — Homo sapiens (Human), Finite cell line (CVCL_F640)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922000/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922000/full.md

## References

246 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922000/full.md

---
Source: https://tomesphere.com/paper/PMC12922000